IBMT mindfulness for Cognitive Decline

Phase-Based Progress Estimates
Arizona State University, Phoenix, AZ
Cognitive Decline+1 More
IBMT mindfulness - Behavioral
All Sexes
What conditions do you have?

Study Summary

The study aims to understand the mechanisms and training effects of evidence-based body-mind training on improving cognitive performance and preventing cognitive decline.

Eligible Conditions

  • Cognitive Decline

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Cognitive Decline

Study Objectives

4 Primary · 3 Secondary · Reporting Duration: The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months

Month 3
Intervention effects on brain function
Intervention effects on brain grey matter
Intervention effects on brain white matter
Month 3
Intervention effects on cognitive decline
Intervention effects on emotion regulation
Intervention effects on mindfulness
Intervention effects on working memory

Trial Safety

Safety Progress

1 of 3

Other trials for Cognitive Decline

Trial Design

2 Treatment Groups

health education
1 of 2
IBMT mindfulness
1 of 2
Active Control
Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: IBMT mindfulness · No Placebo Group · N/A

IBMT mindfulness
Experimental Group · 1 Intervention: IBMT mindfulness · Intervention Types: Behavioral
health education
ActiveComparator Group · 1 Intervention: health education · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: the outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months
Closest Location: Arizona State University · Phoenix, AZ
Photo of Phoenix  1Photo of Phoenix  2Photo of Phoenix  3
2006First Recorded Clinical Trial
1 TrialsResearching Cognitive Decline
63 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.